Answered step by step
Verified Expert Solution
Question
1 Approved Answer
A PATIENT WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE PRESENTS FOR FOLLOW UP. THE PATIENT REPORTS STOPPING SALMETEROL, A LONG ACTING BETA AGONIST, BECAUSE THE SIDE EFFECT
A PATIENT WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE PRESENTS FOR FOLLOW UP. THE PATIENT REPORTS STOPPING SALMETEROL, A LONG ACTING BETA AGONIST, BECAUSE THE SIDE EFFECT OF "HEART RACING'WAS BOTHERSOME. THE NURSE PRACTITIONER COULD CONSIDER SWITCHING TO: A LONG ACTING MUCARINIC ANTAGONIST; A DIFFERENT LONG ACTIGN BETA AGONIST; A COMBINATION LAMA/LABA; OR AN INAHLED CORTICOSTEROID
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started